ArticleActa pharmaceutica Sinica. B2025

Advances in selective targeting of serine hydrolases: A targeted covalent approach against hCES2A mitigates irinotecan toxicity

Elena De VitaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.